REGULATED PRESS RELEASE published on 06/16/2025 at 07:01, 10 months 19 days ago bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of Day Zero Diagnostics solutions and technologies bioMérieux strengthens next-generation sequencing capabilities with acquisition of Day Zero Diagnostics, enhancing rapid diagnostics & antimicrobial stewardship. Acquisition includes NGS workflows, chemistries & software BioMérieux Next-generation Sequencing Rapid Diagnostics Day Zero Diagnostics NGS
BRIEF published on 06/03/2025 at 16:10, 11 months 2 days ago Status of bioMérieux shares and voting rights as of May 2025 Voting Rights BioMérieux Actions Financial Transparency General Regulations
BRIEF published on 06/03/2025 at 07:06, 11 months 2 days ago BioMérieux Introduces Advanced Equine Respiratory Disease Testing BioMérieux Respiratory Diseases PCR Technology Veterinary Diagnostics Equine Health
REGULATED PRESS RELEASE published on 06/03/2025 at 07:01, 11 months 2 days ago bioMérieux launches cutting-edge equine infectious respiratory disease testing bioMérieux launches VETFIRE™ equine infectious disease testing kit, providing rapid PCR results for 7 pathogens. Improving equine health management globally BioMérieux Respiratory Diseases VETFIRE™ Equine PCR
BRIEF published on 05/05/2025 at 11:42, 1 year ago Number of shares and voting rights at bioMérieux in April 2025 Share Capital Voting Rights BioMérieux Actions 2025
BRIEF published on 04/22/2025 at 07:06, 1 year ago BioMérieux Launches WATCHFIRE™: A New PCR Test for Wastewater Surveillance BioMérieux Pathogen Detection WATCHFIRE™ Wastewater Surveillance PCR Testing
REGULATED PRESS RELEASE published on 04/22/2025 at 07:01, 1 year ago WATCHFIRE™ by bioMérieux: a PCR test to detect viruses and bacteria in wastewater and respond to potential infectious disease outbreaks bioMérieux launches WATCHFIRE™, a PCR test detecting viruses and bacteria in wastewater to monitor infectious disease outbreaks. Revolutionary solution for public health BioMérieux PCR Test WATCHFIRE™ Wastewater Infectious Disease Outbreaks
BRIEF published on 04/17/2025 at 07:06, 1 year ago BioMérieux Reports Strong First-Quarter 2025 Growth BioMérieux GO•28 Strategic Plan Q1 2025 Growth SPOTFIRE® Sales CEBIT Projections
REGULATED PRESS RELEASE published on 04/17/2025 at 07:01, 1 year ago bioMérieux – First-Quarter 2025 Business Review bioMérieux reports strong Q1 2025 results with +12.7% organic sales growth, reiterates sales guidance of +7% with steady CEBIT growth. Acquisition of Neoprospecta and SpinChip boosts Point of Care presence Acquisition BioMérieux Organic Sales Growth Q1 2025 CEBIT Growth
BRIEF published on 04/07/2025 at 07:06, 1 year ago BioMérieux Achieves CE Marking for LUMED™ APSS™ to Enhance Antimicrobial Stewardship BioMérieux Healthcare Antimicrobial Stewardship CE Marking LUMED APSS
Published on 05/06/2026 at 02:17, 3 hours 46 minutes ago Troubadour Announces Share Consolidation and Effective Date
Published on 05/06/2026 at 02:00, 4 hours 3 minutes ago Vanta Announces Closing of First Tranche of Private Placement and Debt Settlement
Published on 05/06/2026 at 02:00, 4 hours 3 minutes ago Alset AI Announces Shares for Debt Transaction
Published on 05/06/2026 at 01:30, 4 hours 33 minutes ago Presentation to RIU Sydney Resources Roundup
Published on 05/06/2026 at 01:20, 4 hours 43 minutes ago Empress Grants Stock Options and Equity Incentives
Published on 05/06/2026 at 03:05, 2 hours 58 minutes ago ARC Group Advises Magnax on €35.5 Million Strategic Investment from Pan-International Industrial Corp. and Foxconn Group
Published on 05/06/2026 at 03:05, 2 hours 58 minutes ago Bank of America Convenes Global Leaders in Asia Pacific for its Breakthrough Technology Dialogue
Published on 05/06/2026 at 01:35, 4 hours 28 minutes ago VERNAL CAPITAL ACQUISITION CORP. ANNOUNCES PRICING OF $100 MILLION INITIAL PUBLIC OFFERING
Published on 05/06/2026 at 00:05, 5 hours 58 minutes ago ESOC 2026: Rising stroke rates highlight widening ethnic and socioeconomic inequalities across populations, major study finds
Published on 05/05/2026 at 23:05, 6 hours 58 minutes ago Norgine welcomes TGA registration in Australia of PEDMARQSI® (sodium thiosulfate anhydrous) for the prevention of cisplatin-induced hearing loss in children1
Published on 05/05/2026 at 19:00, 11 hours 3 minutes ago Combined General Meeting of Air Liquide Shareholders of May 5, 2026
Published on 05/05/2026 at 18:03, 12 hours ago Aéroports de Paris SA - Shares and voting rights as of 30 April 2026
Published on 05/05/2026 at 17:53, 12 hours 10 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - April 2026